unknown
Stage
4
Investors
About
Genesis Molecular AI develops AI models and research infrastructure to accelerate small-molecule drug discovery, building molecular-scale world models and partnering with biopharma companies. The company applies domain-specific machine learning to generate and evaluate candidate molecules for therapeutic development.
Explore Genesis Molecular AI's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.